1. Home
  2. CACI vs RDY Comparison

CACI vs RDY Comparison

Compare CACI & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CACI International Inc.

CACI

CACI International Inc.

HOLD

Current Price

$633.27

Market Cap

10.9B

Sector

Technology

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$12.44

Market Cap

9.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CACI
RDY
Founded
1962
1984
Country
United States
India
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
9.9B
IPO Year
2007
2001

Fundamental Metrics

Financial Performance
Metric
CACI
RDY
Price
$633.27
$12.44
Analyst Decision
Buy
Strong Buy
Analyst Count
12
1
Target Price
$689.50
$16.90
AVG Volume (30 Days)
233.9K
2.2M
Earning Date
04-22-2026
05-12-2026
Dividend Yield
N/A
0.52%
EPS Growth
8.24
N/A
EPS
24.16
N/A
Revenue
$4,467,860,000.00
N/A
Revenue This Year
$12.42
$7.72
Revenue Next Year
$10.00
$3.50
P/E Ratio
$25.92
$18.67
Revenue Growth
2.60
N/A
52 Week Low
$434.70
$11.36
52 Week High
$683.50
$15.67

Technical Indicators

Market Signals
Indicator
CACI
RDY
Relative Strength Index (RSI) 57.11 59.34
Support Level $601.15 $12.09
Resistance Level $683.45 $12.48
Average True Range (ATR) 17.39 0.18
MACD -2.69 0.06
Stochastic Oscillator 80.32 97.88

Price Performance

Historical Comparison
CACI
RDY

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: